ArticleAnnals of medicine and surgery (2012)2025
Intravitreal ziv-aflibercept for myopic macular neovascularization after pars plana vitrectomy and silicone oil tamponade: a case report.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Myopic macular neovascularization (mMNV) is a significant complication of pathological myopia, leading to vision impairment. The primary treatment involves anti-VEGF therapy, with ziv-aflibercept emerging as a cost-effective alternative to traditional therapies. However, the presence of silicone oil in the vitreous cavity, often used in complex vitreoretinal surgeries, poses challenges for drug delivery. This case report aims to explore the efficacy of intravitreal ziv-aflibercept in treating mMNV in a silicone oil-filled eye. Case presentation: A 66-year-old woman with a history of high myopia underwent vitrectomy and silicone oil tamponade. She presented with significantly reduced visual acuity. Spectral-domain optical coherence tomography (SD-OCT) imaging revealed mMNV, subretinal fluid, and signs of hypotony in her right eye. Given these findings, the patient was administered an intravitreal injection of ziv-aflibercept. Clinical discussion: Post-injection, the patient exhibited marked improvements, including enhanced visual acuity improving to counting fingers at a distance of 2 m and decreased intraocular pressure to 6 mmHg. SD-OCT imaging demonstrated resolution of subretinal fluid, indicating successful treatment of mMNV. These positive outcomes were maintained over a follow-up period of 6 months, suggesting that ziv-aflibercept can effectively manage mMNV even in the presence of silicone oil. Conclusion: Intravitreal ziv-aflibercept injection is a viable early treatment option for patients with mMNV in silicone oil-filled eyes. This case highlights its potential to achieve mMNV regression and improve visual acuity, thereby preventing irreversible vision loss in affected individuals. Further studies are warranted to establish standardized protocols for its use in similar clinical scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.